Skip to content

Adjuvant drug mixing with local anaesthetic in USG guided brachial plexus block

Dexmedetomiodine as an adjuvant to levobupivacaine in ultrasonography guided supraclavicular brachial plexus block - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061388
Enrollment
60
Registered
2024-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S523- Fracture of shaft of radius

Interventions

Intervention1: usg guided supraclavicular brachial plexus block: two groups are compared for onset and and duration sensory and motor block .the duration of study will be for 1 year . Control Interven

Sponsors

Gandhi Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: study will be carried out on 60 patient of ASA grade 1 and grade 2 for upper limb surgeries ,after clearance from ethical committee.patient will under go pre-anaesthetic check up ,wrritten informed consent will be obtained . patiet will receive either 30 ml levobupivacaine with adjuvant dexmedetomidine or normal saline for supraclavicular brachial plexus block under usg guidance.

Exclusion criteria

Exclusion criteria: 1)age 60 years 2)pregnancy 3)infection at puncture site 4)coagulopathy 5)allery to local anaesthetic 6)psychiatric illness 7)Neuropathy 8)brachial plexus injury

Design outcomes

Primary

MeasureTime frame
1)to evaluate onset of sensory & motor blockade with dexmedetomidine as an adjuvant to levobupivacaine . 2)to evaluate effect of dexmedetomidine with levobupivacaine on duration of motor and sensory block and duration of analgesia.Timepoint: sensory and motor blockade will be observed at 5 ,10 ,15 ,30 ,45 ,60 ,75 ,90 ,105 , 120 minutes

Secondary

MeasureTime frame
1)to observe sedation effect of dexmedetomidine 2)to obsrve effect of dexmedetomidine on duration of analgesiaTimepoint: at 5 ,10 ,15 ,30 ,45 ,60 ,75 ,90 ,105 , 120 minutes

Countries

India

Contacts

Public ContactDr Tripti Vatsalya

Ganhdi Medical College, Bhopal

vdrtripti@gmail.com7974219518

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026